DENTSPLY SIRONA Inc
XMUN:DY2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DENTSPLY SIRONA Inc
XMUN:DY2
|
US |
|
N
|
NTT Data Corp
OTC:NTTDF
|
JP |
|
SoftBank Corp
TSE:9434
|
JP |
|
APi Group Corp
F:4XY
|
US |
|
Koninklijke Ahold Delhaize NV
F:AHOD
|
NL |
|
Azienda Bresciana Petroli Nocivelli SpA
MIL:ABP
|
IT |
|
Z
|
Zions Bancorporation NA
F:ZB1
|
US |
|
S
|
Starbucks Corp
XETRA:SRB
|
US |
|
Bayan Resources Tbk PT
F:BNB
|
ID |
|
China Yangtze Power Co Ltd
SSE:600900
|
CN |
|
Mitsubishi Electric Corp
F:MIE
|
JP |
|
L
|
Leidos Holdings Inc
F:S6IA
|
US |
|
D
|
Daikin Industries Ltd
XBER:DKI
|
JP |
|
I
|
Industria de Diseno Textil SA
SWB:IXD1
|
ES |
|
F
|
FedEx Corp
XHAM:FDX
|
US |
|
C
|
Conocophillips
XBER:YCP
|
US |
|
A
|
AXA SA
SWB:AXA
|
FR |
|
Volvo AB
OTC:VOLAF
|
SE |
|
Commerzbank AG
XETRA:CBK
|
DE |
|
C
|
China Literature Ltd
SWB:C2X
|
CN |
|
F
|
First Advantage Corp
F:0MS
|
US |
|
M
|
Mueller Die lila Logistik SE
XBER:MLL
|
DE |
|
Kuaishou Technology
HKEX:81024
|
CN |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
DENTSPLY SIRONA Inc
DENTSPLY SIRONA makes equipment and supplies for dentists and dental labs. Its products include imaging systems, dental chairs and treatment units, drill and handpiece tools, digital scanning and design systems, implant parts, and everyday consumables such as endodontic and restorative materials. It also sells service, software, and replacement parts to keep those systems running. Its main customers are dental practices, clinics, dental laboratories, and distributors that serve those buyers. The company makes money by selling a mix of higher-ticket equipment and recurring consumable products, which means customers may buy a system once but keep coming back for materials, accessories, and service support over time. What makes the business model distinct is that it sits close to the core of dental care: it supplies both the devices used in the chair and the materials used in treatment. That gives it a broad role in the dental workflow, from diagnosis and planning to treatment and maintenance, rather than relying on just one narrow product category.
DENTSPLY SIRONA makes equipment and supplies for dentists and dental labs. Its products include imaging systems, dental chairs and treatment units, drill and handpiece tools, digital scanning and design systems, implant parts, and everyday consumables such as endodontic and restorative materials. It also sells service, software, and replacement parts to keep those systems running.
Its main customers are dental practices, clinics, dental laboratories, and distributors that serve those buyers. The company makes money by selling a mix of higher-ticket equipment and recurring consumable products, which means customers may buy a system once but keep coming back for materials, accessories, and service support over time.
What makes the business model distinct is that it sits close to the core of dental care: it supplies both the devices used in the chair and the materials used in treatment. That gives it a broad role in the dental workflow, from diagnosis and planning to treatment and maintenance, rather than relying on just one narrow product category.
Results: DENTSPLY SIRONA reported first-quarter revenue of $880 million, with constant-currency sales down 6.7% and adjusted EPS of $0.27.
Outlook: Management kept full-year 2026 guidance unchanged at $3.5 billion to $3.6 billion of net sales and adjusted EPS of $1.40 to $1.50.
Turnaround: The company said Q1 was the start of its Return-to-Growth plan, with early actions focused on U.S. commercial restructuring, clinical education, cost cuts and new distribution agreements.
Margins: Adjusted EBITDA margin fell 430 basis points, pressured by lower volume, mix and tariffs, though OpEx fell $20 million on a constant-currency basis.
Growth pockets: Wellspect Healthcare grew 3.4% constant currency, while APAC and EMEA showed pockets of strength in several businesses even as the overall quarter remained weak.
Timing: Management said many benefits from the turnaround will build later in 2026, with more meaningful improvement expected in 2027 and 2028.
Capital: The company retired about $80 million of debt in the quarter and said it will consider share repurchases later this year after further deleveraging.
